-
Most Popular
Search Results
240 results for COV
BVXV Stock Alert: The Covid-19 Antibody News Sending BiondVax Pharma Soaring
Biondvax Pharmaceuticals (BVXV) stock is on the rise Wednesday thanks to some positive news concerning its Covid-19 antibodies.
CYTO Stock: The Nasal Spray News Blowing Altamira Therapeutics Sky-High Today
Altamira Therapeutics (CYTO) stock is rocketing higher on Friday following the release of positive results from a nasal spray test.
ARDS Stock Alert: The Covid-19 News Sending Aridis Skyrocketing Today
Aridis Pharmaceuticals has a new cocktail, and it may be the ticket out of the omicron variant. Here’s why ARDS stock is worth watching.
Short-Squeeze Stocks Alert: CVNA, NVAX Make Most-Shorted Stocks List
Business news outlet CNBC recently posted its list of top short-squeeze stocks, which present potentially lucrative though risky ideas.
Novavax Is Inching Closer, But Its Vaccine Better Be Special
Novavax is trailing the competition in the coronavirus vaccine race, but markets may be punishing NVAX stock too much.
Hologic Stock Rides High on Strength of Coronavirus Testing
Hologic has carved out a meaningful niche in women’s health. But it’s coronavirus testing driving HOLX stock higher these days.
3 Stocks With the Largest 52-Week Losses
Although the stocks with largest 52-week losses are inherently risky, when the right ones are selected, they may also provide opportunities.
Upgrades This Week – BA, GIS, MSFT, NKE, PFE, GSK, MRK
Boeing (BA), General Mills (GIS), Microsoft (MSFT), and Nike (NKE) were among the widely-held stocks upgraded by Louis Navellier in his latest fundamental stock analysis…
Ocugen Stock Is a Risky Proposition Despite Its High Valuation
OCGN stock soared on a deal to commercialize Bharat Biotech’s Covaxin in the U.S., but the rollout comes with a lot of challenges.
3 Healthcare Acquisitions Google Should Consider
The best way for Google to make an even bigger splash in healthcare is through smart acquisitions like these 3 companies.
I Would Not Be Surprised If SRNE Stock Trades Below $5
SRNE stock is a purely speculative bet. The company has a deep pipeline of Covid-19 programs. But there is little progress or positive outcome.
Soft CPI Data Crushes Inflation Fears – And Sets Stocks Up for a Summer Surge
April’s CPI report shows inflation cooling across key sectors, defying tariff fears and fueling a market rally.
There Is More To Pfizer Than The Covid Vaccine
Pfizer is a lot more than the covid vaccine. PFE stock has strong growth potential and is a great dividend stock for 2021.
Inovio Stock Poised for Growth as Preliminary Research Shows Promise
Vaccine trials are in progress, and although it isn’t the only player on the field, Inovio stock has a clear head-start on the competition.
It’s OK to Sell the News on Ocugen and Covaxin
OCGN stock jumped when Covaxin received WHO approval. But with two major obstacles in the way of U,S. approval, you should sell the news.
Novavax Is Looking More Like a Bet Worth Taking
NVAX stock fell behind other vaccine plays early in 2021, but it might not stay behind, There’s lots of evidence to suggest it could move…
10 – 10 of 240 results
